Cyclooxygenase-2 expression in clear cell renal cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Immunohistochemistry

Background:

• Cyclooxygenase-2 (COX-2) is implicated in cancer progression, promoting proliferation and angiogenesis while inhibiting apoptosis.
• COX-2 is frequently overexpressed in various malignancies, including renal cell carcinoma (RCC).

Purpose of the Study:

• To investigate the expression of COX-2 in clear cell RCC.
• To determine the association between COX-2 expression and clinicopathological parameters such as tumor grade, age, sex, and ethnicity.

Main Methods:

• Analysis of 36 clear cell RCC tissue samples.
• Immunohistochemical staining using a COX-2 monoclonal antibody.
• Evaluation of COX-2 expression patterns and correlation with demographic and tumor characteristics.

Main Results:

• COX-2 expression was observed in 18 (50%) of the RCC cases, all exhibiting strong positivity.
• Immunopositive cases demonstrated cytoplasmic membrane localization of COX-2.
• No significant associations were found between COX-2 expression and tumor grade (p=0.457), age (p=0.054), sex (p=0.389), or ethnicity (p=0.568).

Conclusions:

• Strong COX-2 positivity in clear cell RCC suggests its potential role in cell proliferation and carcinogenesis.
• Despite overexpression, COX-2 levels did not correlate with key clinicopathological features in this cohort.